Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Asia Sejahtera Mina Tbk (AGAR) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Asia Sejahtera Mina TbkTrade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Asia Sejahtera Mina Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Asia Sejahtera Mina Tbk trades at Rp1,605 (market cap 1.29T, 1.47M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 31.1K 24h volume). The key difference: Asia Sejahtera Mina Tbk is far larger — about 7.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Asia Sejahtera Mina Tbk is more actively traded (1.47M versus 31.1K). Which is the better fit depends on your goals.

AGAROBAT
Market Cap
1.29T164.65B
Volume
1.47M31.1K
Lot
14.75K311
Turnover
2.34B7.51M
Average Price
1,588.75241.62
Value
2.34B7.51M
Indicative Equilibrium Price
1,445238
Indicative Equilibrium Volume
253100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AGAR
View details
OBAT
View details

About Asia Sejahtera Mina Tbk

PT Asia Sejahtera Mina Tbk (the Company) was established based on Notarial Deed No. 12 dated August 27, 2008 of Amelia Kasih, S.H., MKn. The parent company of the Company is PT Sinar Terang Asia Raya and the main parent entity is PT Indo Kreasi Pratama, both of which were established in Indonesia.

Read more on AGAR

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT